Related references
Note: Only part of the references are listed.Targeted proteomics of right heart adaptation to pulmonary arterial hypertension
Myriam Amsallem et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification JACC State-of-the-Art Review
William M. Oldham et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Lipids and ketones dominate metabolism at the expense of glucose control in pulmonary arterial hypertension: a hyperglycaemic clamp and metabolomics study
Jacob T. Mey et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Metabolomics reveals metabolite changes of patients with pulmonary arterial hypertension in China
Chenyang Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Pulmonary Arterial Hypertension Induces a Distinct Signature of Circulating Metabolites
Ruslan Rafikov et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Serum High-Density Lipoprotein Cholesterol is Significantly Associated with the Presence and Severity of Pulmonary Arterial Hypertension: A Retrospective Cross-Sectional Study
Gao-Feng Wang et al.
ADVANCES IN THERAPY (2020)
LncRNA CASC2 inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation and migration by regulating the miR-222/ING5 axis
Yan Han et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2020)
Prognostic impact of red blood cell distribution width in pulmonary hypertension patients A systematic review and meta-analysis
Jie Liu et al.
MEDICINE (2020)
Role of Extracellular Vesicles in Pulmonary Arterial Hypertension Modulation of Pulmonary Endothelial Function and Angiogenesis
Avinash Khandagale et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension
Yang-Yang He et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Noninvasive Prediction of Elevated Wedge Pressure in Pulmonary Hypertension Patients Without Clear Signs of Left-Sided Heart Disease: External Validation of the OPTICS Risk Score
Samara M. A. Jansen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Prognostic Value of Gamma-Glutamyltransferase in Male Patients With Idiopathic Pulmonary Arterial Hypertension
Gang-Hua Lu et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Plasma metabolomic profile in chronic thromboembolic pulmonary hypertension
Gustavo A. Heresi et al.
PULMONARY CIRCULATION (2020)
Impaired Blood Rheology in Pulmonary Arterial Hypertension
Yalin Tolga Yaylali et al.
HEART LUNG AND CIRCULATION (2019)
Platelet and coagulation disorders in newly diagnosed patients with pulmonary arterial hypertension
Eleni Vrigkou et al.
PLATELETS (2019)
Predicting Survival in Patients With Pulmonary Arterial Hypertension The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies
Raymond L. Benza et al.
CHEST (2019)
Elevated plasma Pim-1 and its clinical significance in patients with pulmonary arterial hypertension
Tengteng Zhu et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2019)
Use of red cell distribution width in a population at high risk for pulmonary hypertension
Laura A. Petrauskas et al.
RESPIRATORY MEDICINE (2019)
Learning from registries in pulmonary arterial hypertension: pitfalls and recommendations
Katleen Swinnen et al.
EUROPEAN RESPIRATORY REVIEW (2019)
Human PAH is characterized by a pattern of lipid-related insulin resistance
Anna R. Hemnes et al.
JCI INSIGHT (2019)
Metabolomics of exercise pulmonary hypertension are intermediate between controls and patients with pulmonary arterial hypertension
Jason L. Sanders et al.
PULMONARY CIRCULATION (2019)
Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension
Habib Bouzina et al.
PULMONARY CIRCULATION (2019)
Distinct plasma gradients of microRNA-204 in the pulmonary circulation of patients suffering from WHO Groups I and II pulmonary hypertension
Leonard E. Estephan et al.
PULMONARY CIRCULATION (2019)
Interleukin-6 is independently associated with right ventricular function in pulmonary arterial hypertension
Kurt W. Prins et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2018)
Angiogenic and inflammatory biomarkers for screening and follow-up in patients with pulmonary arterial hypertension
D. Kylhammar et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2018)
Red blood cell distribution width as a related factor of pulmonary arterial hypertension in patients with systemic sclerosis
Jiuliang Zhao et al.
CLINICAL RHEUMATOLOGY (2018)
MicroRNA-424(322) as a new marker of disease progression in pulmonary arterial hypertension and its role in right ventricular hypertrophy by targeting SMURF1
Rui Baptista et al.
CARDIOVASCULAR RESEARCH (2018)
Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension
Christopher J. Rhodes et al.
CIRCULATION (2017)
Long-Term Survival and Apolipoprotein A1 Level in Chronic Heart Failure: Interaction With Tumor Necrosis Factor α-308 G/A Polymorphism
Timea Gombos et al.
JOURNAL OF CARDIAC FAILURE (2017)
Angiogenic and inflammatory biomarkers in the differentiation of pulmonary hypertension
Joanna Saleby et al.
SCANDINAVIAN CARDIOVASCULAR JOURNAL (2017)
Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study
Christopher J. Rhodes et al.
LANCET RESPIRATORY MEDICINE (2017)
Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension
Grzegorz Kopec et al.
SCIENTIFIC REPORTS (2017)
Abnormal Glucose Metabolism and High-Energy Expenditure in Idiopathic Pulmonary Arterial Hypertension
Gustavo A. Heresi et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2017)
miR-4632 mediates PDGF-BB-induced proliferation and antiapoptosis of human pulmonary artery smooth muscle cells via targeting cJUN
Zhengjiang Qian et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2017)
Lack of elevation in plasma levels of pro-inflammatory cytokines in common rodent models of pulmonary arterial hypertension: questions of construct validity for human patients
Kenny Schlosser et al.
PULMONARY CIRCULATION (2017)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
Non-suppressive regulatory T cell subset expansion in pulmonary arterial hypertension
Yoshiharu Sada et al.
HEART AND VESSELS (2016)
CD133+ cells in pulmonary arterial hypertension
Vasile Foris et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension
Laurent Calvier et al.
HEART (2016)
Plasma Levels of Receptor for Advanced Glycation End-Products and High-Mobility Group Box 1 in Patients With Pulmonary Hypertension
Satoshi Suzuki et al.
INTERNATIONAL HEART JOURNAL (2016)
New Biochemical Insights into the Mechanisms of Pulmonary Arterial Hypertension in Humans
Renata Bujak et al.
PLOS ONE (2016)
Plasma 12-and 15-hydroxyeicosanoids are predictors of survival in pulmonary arterial hypertension
Nadine Al-Naamani et al.
PULMONARY CIRCULATION (2016)
T-Helper 17 Cell Polarization in Pulmonary Arterial Hypertension
Aurelie Hautefort et al.
CHEST (2015)
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
J. Gerry Coghlan et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Platelets Are Highly Activated in Patients of Chronic Thromboembolic Pulmonary Hypertension
Nobuhiro Yaoita et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Adiponectin Levels Are Elevated in Patients With Pulmonary Arterial Hypertension
Mario Santos et al.
CLINICAL CARDIOLOGY (2014)
Serum levels of CD163 and TWEAK in patients with pulmonary arterial hypertension
Malgorzata Jasiewicz et al.
CYTOKINE (2014)
Uric acid and risk of heart failure: a systematic review and meta-analysis
He Huang et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Impact of insulin resistance on ventricular function in pulmonary arterial hypertension
Nathan W. Brunner et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2014)
Cystatin C: A potential biomarker for pulmonary arterial hypertension
Brett E. Fenster et al.
RESPIROLOGY (2014)
Fibrinogen plasma concentration is an independent marker of haemodynamic impairment in chronic thromboembolic pulmonary hypertension
Jan K. Hennigs et al.
SCIENTIFIC REPORTS (2014)
Erythropoietin upregulation in pulmonary arterial hypertension
Vanesa A. Karamanian et al.
PULMONARY CIRCULATION (2014)
Markers of Thrombogenesis and Fibrinolysis and Their Relation to Inflammation and Endothelial Activation in Patients with Idiopathic Pulmonary Arterial Hypertension
Grzegorz Kopec et al.
PLOS ONE (2013)
Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension
Nils P. Nickel et al.
RESPIRATORY RESEARCH (2013)
Professional killer cell deficiencies and decreased survival in pulmonary arterial hypertension
Adrienne L. Edwards et al.
RESPIROLOGY (2013)
Pim-1: A new biomarker in pulmonary arterial hypertension
Sebastien Renard et al.
PULMONARY CIRCULATION (2013)
Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertension
Rajeev Malhotra et al.
PULMONARY CIRCULATION (2013)
Association between neutrophil to lymphocyte ratio and pulmonary arterial hypertension
Abdulkadir Yildiz et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2013)
Increased CD39 Nucleotidase Activity on Microparticles from Patients with Idiopathic Pulmonary Arterial Hypertension
Scott H. Visovatti et al.
PLOS ONE (2012)
Safety and Feasibility of Obtaining Wedged Pulmonary Artery Samples and Differential Distribution of Biomarkers in Pulmonary Hypertension
Wassim H. Fares et al.
Pulmonary Circulation (2012)
Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities
Samar Farha et al.
BLOOD (2011)
Platelet Indices in Patients With Pulmonary Arterial Hypertension
Ercan Varol et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2011)
High Levels of Zinc-Protoporphyrin Identify Iron Metabolic Abnormalities in Pulmonary Arterial Hypertension
Ilka Decker et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2011)
Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension
Christopher J. Rhodes et al.
HEART (2011)
Systemic Oxidative Stress and Endothelial Dysfunction is Associated With an Attenuated Acute Vascular Response to Inhaled Prostanoid in Pulmonary Artery Hypertension Patients
Luigi A. Gabrielli et al.
JOURNAL OF CARDIAC FAILURE (2011)
Progressive Right Ventricular Dysfunction in Patients With Pulmonary Arterial Hypertension Responding to Therapy
Marielle C. van de Veerdonk et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Baseline Low-Density Lipoprotein Cholesterol Levels and Outcome in Patients With Heart Failure
Gideon Charach et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension
Elaine Soon et al.
CIRCULATION (2010)
Distinct patterns of circulating endothelial cells in pulmonary hypertension
D. M. Smadja et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Enhanced hemostatic indices in patients with pulmonary arterial hypertension: An observational study
Mehmet Mustafa Can et al.
THROMBOSIS RESEARCH (2010)
Evidence of Dysfunction of Endothelial Progenitors in Pulmonary Arterial Hypertension
Mark Toshner et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Insulin resistance in pulmonary arterial hypertension
R. T. Zamanian et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
C-Reactive Protein A New Predictor of Adverse Outcome in Pulmonary Arterial Hypertension
Rozenn Quarck et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Potential diagnostic biomarkers in serum of idiopathic pulmonary arterial hypertension
Jianqiang Zhang et al.
RESPIRATORY MEDICINE (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension
Benjamin Terrier et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension
Gerhard-Paul Diller et al.
CIRCULATION (2008)
Hemodynamic variables and clinical features correlated with serum uric acid in patients with pulmonary arterial hypertension
Jiang Xin et al.
CHINESE MEDICAL JOURNAL (2008)
C-reactive protein and asymmetric dimethylarginine: Markers or mediators in cardiovascular disorders?
Caroline L. Smith
CURRENT PHARMACEUTICAL DESIGN (2007)
N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension
Arne K. Andreassen et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension
Anna Fijalkowska et al.
CHEST (2006)
Identification of plasma protein biomarkers associated with idiopathic pulmonary arterial hypertension
VB Abdul-Salam et al.
PROTEOMICS (2006)
Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension
T Itoh et al.
RESPIROLOGY (2006)
Pathobiology of pulmonary hypertension - The role of platelets and thrombosis
P Herve et al.
CLINICS IN CHEST MEDICINE (2001)
High plasma serotonin levels in primary pulmonary hypertension -: effect of long-term epoprostenol (prostacyclin) therapy
A Kéreveur et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Share Paper
